Acute and long-term administration of citalopram desensitizes alpha2-adrenoceptors in the rat vas deferens

The Journal of Pharmacy and Pharmacology
Laura GrandosoL Ugedo

Abstract

The aim of this study was to investigate the effect of citalopram, a selective serotonin reuptake inhibitor, on the sensitivity of rat vas deferens alpha2-adrenoceptors and to compare it with the effects of serotonin and the dual noradrenaline-serotonin uptake inhibitor duloxetine. To this end, we studied the inhibitory effect of the alpha2-adrenoceptor agonist bromoxidine on the electrically induced contraction of the vas deferens. Citalopram (1, 3 x 10(3) and 3 x 10(4) nM) applied in-vitro significantly attenuated the concentration-response inhibition induced by activation of alpha2-adrenoceptors on the electrically evoked contraction of the vas deferens (concentration of the agonist required to promote 50% of the maximal effect, EC50, for bromoxidine increased by 232%, 421% and 818%, respectively). Similarly, serotonin also attenuated the concentration-response inhibition mediated by presynaptic alpha2-adrenoceptors (96% increase in EC50). Acute and long-term systemic administration of citalopram and duloxetine also produced a loss in the sensitivity of alpha2-adrenoceptors to bromoxidine (EC50 for bromoxidine increased by 97% and 144%, respectively, after citalopram, and by 214% and 167% after duloxetine). In addition, we o...Continue Reading

References

Jul 1, 1989·Physiological Reviews·K StarkeH Kilbinger
Jan 1, 1968·Zeitschrift für Zellforschung und mikroskopische Anatomie·G J Etcheverry, L M Zieher
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Oct 3, 1999·Journal of Clinical Psychopharmacology·P Popik
Dec 22, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L BuschE Borda
Jul 17, 2001·Biological Psychology·F Holsboer
Jul 31, 2001·International Journal of Impotence Research·K E Andersson
Mar 15, 2002·Drugs·Antona J WagstaffKaren L Goa
Jul 12, 2002·British Journal of Pharmacology·Linda ClearyJames R Docherty
Aug 7, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ersin YarisRasin Ozyavuz
Nov 25, 2003·The Annals of Pharmacotherapy·David E Adson, Michael Kotlyar
Mar 11, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerard SanacoraDennis S Charney
May 19, 2004·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Paolo Cassano, Maurizio Fava

❮ Previous
Next ❯

Citations

Aug 19, 2007·Journal of Psychiatric Research·M Flechtner-MorsH H Ditschuneit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.